Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-021723
Filing Date
2025-11-12
Accepted
2025-11-12 07:35:53
Documents
82
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1281186
2 EX-31.1 ex31-1.htm EX-31.1 15049
3 EX-31.2 ex31-2.htm EX-31.2 14989
4 EX-32 ex32.htm EX-32 10989
  Complete submission text file 0001493152-25-021723.txt   7334982

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abeo-20250930.xsd EX-101.SCH 48749
6 XBRL CALCULATION FILE abeo-20250930_cal.xml EX-101.CAL 72473
7 XBRL DEFINITION FILE abeo-20250930_def.xml EX-101.DEF 212760
8 XBRL LABEL FILE abeo-20250930_lab.xml EX-101.LAB 471600
9 XBRL PRESENTATION FILE abeo-20250930_pre.xml EX-101.PRE 384675
84 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1212226
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 251468877
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)